SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-001356
Filing Date
2022-01-07
Accepted
2022-01-07 16:15:16
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3453
  Complete submission text file 0000899243-22-001356.txt   4797
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT ST. BOULDER CO 80301
Business Address
Oltmans Curtis Gale (Reporting) CIK: 0001714982 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38978 | Film No.: 22518297